Join us for our webinar where expert speakers delve into the transformative impact of artificial intelligence (AI) on clinical trials. This event is part of a two-part webinar series designed to explore how AI is revolutionizing clinical development and fostering innovation with greater confidence.
In this second installment, our speakers will discuss how AI and machine learning mitigate risks from study design through operationalization. They will highlight how these technologies lower patient and site burden, reduce complexity, enable real-time scenario planning, and empower strategic decision-making.
Key topics of discussion will include:
- Catalyzing Rapid Innovation: Discover how the integration of AI, comprehensive data, and deep industry knowledge is driving rapid innovation across research and development
- Risk Identification and Reduction: Learn how AI-powered technologies identify potential risks in study design, thereby reducing patient and site burden while simplifying complex scenarios
- Optimal Scenario Planning: Understand the benefits of AI in scenario planning, which aids in crafting optimal global enrollment strategies and informed site selection
- Operational Efficiency: Explore how AI tools seamlessly integrate to reduce operational complexities and ensure adherence to regulatory standards
Register now to gain valuable insights into the transformative impact of AI in clinical trials and stay ahead in the rapidly evolving landscape of clinical development.
Speakers
Raja Shankar, VP, Machine Learning, IQVIA
Raja Shankar is focused on transforming life sciences with Applied AI. As the VP for Machine Learning, Raja is determined to change healthcare with the power of AI. He believes that imagination is the biggest barrier and motivates his team to create new narratives that fully leverage AI’s potential to reshape the industry from R&D through commercialization.
Raja brings together a diverse set of technical and strategic capabilities, including machine learning, deep learning, generative AI, product development, life sciences expertise and business consulting skills. His team combines data science, domain expertise and consulting skills to create “superhero” change makers who drive impactful change by applying AI to life sciences and healthcare decisions.
Raja is a trusted advisor to global life sciences companies, public sector clients, as well as international organizations.
Message Presenter
Stephen Hampton, Director, Enterprise Architecture – Generative AI, IQVIA
Stephen Hampton is driven by a passion for collaboration and a customer-first approach to the delivery of novel technology. As Director of Enterprise Architecture for Generative AI at IQVIA, he is dedicated to transforming clinical research through AI/ML innovation. With a strong foundation in technical consulting and product strategy, Stephen has supported global life sciences companies in healthcare and pharmaceutical industries.
He partners with IQVIA teams to integrate technology strategy with business acumen to revolutionize clinical trial processes, spanning drug discovery to commercialization. Stephen draws on his extensive background in enterprise systems, process optimization, and product development to identify, evaluate and advance innovative Generative AI solutions that create value for IQVIA customers.
Message PresenterWho Should Attend?
This webinar will appeal to senior professionals (Director level and above) working in pharma and biotech companies or having the following job titles:
- Clinical operations
- Digital Innovation Leads
- Procurement
- Therapeutic Leads
- Centralized Monitoring
What You Will Learn
Attendees will learn about:
- How the merger of AI, comprehensive data and industry acumen enables rapid innovation across R&D
- How AI-powered technology can uncover potential study design risks by identifying areas of patient burden and complexity
- How AI enhances scenario planning to devise optimal global enrollment strategies and inform site selection
- The value of integrated AI tools for reducing operational and regulatory risk
Xtalks Partner
IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account